Hepatitis C: latest news

Hepatitis C resources

  • How hepatitis C is passed on during sex

    Hepatitis C can be passed on during sex that could lead to contact with semen, rectal mucus or blood.Many gay men with HIV have picked...

    From: The basics

    Information level Level 1
  • Hepatitis C

    A blood test for antibodies will show if you have been exposed to hepatitis C.HIV treatment has particular benefits for people with HIV and hepatitis...

    From: Factsheets

    Information level Level 2
  • Hepatitis C

    Hepatitis C can cause the same types of symptoms and long-term liver damage as hepatitis B, though the two viruses are not related. Recent estimates find that...

    From: Booklets

    Information level Level 2
  • HIV & hepatitis

    This booklet gives information for people with HIV who also have hepatitis A, hepatitis B or hepatitis C....

    From: Booklets

    Information level Level 2
  • Hepatitis C

    Hepatitis C is a serious infection caused by a virus.It damages the liver, which performs essential functions in the body.Some people have hepatitis C for...

    From: The basics

    Information level Level 1
  • Hepatitis C treatment

    Deciding on the best time to take treatment for hepatitis C is not straightforward.It’s important to get support and advice to help you with this...

    From: The basics

    Information level Level 1
  • How hepatitis C is passed on

    When the blood of a person who has hepatitis C enters the bloodstream of another person, that person could get hepatitis C.Tiny and unseen traces...

    From: The basics

    Information level Level 1

Hepatitis C features

Hepatitis C in your own words

Hepatitis C news from aidsmap

More news

Hepatitis C news selected from other sources

  • From chronic to cured: could Australia be the first country in the world to eliminate hep C?

    Australia is on track to eliminate hepatitis C by 2026, a new report released by the Kirby Institute on World Hepatitis Day shows.

    28 July 2017 | Kirby Institute
  • WHO prequalifies first generic hepatitis C medicine and first HIV self-test

    WHO today prequalified the first generic version of sofosbuvir, a critical medicine for the treatment of hepatitis C. The development could expand access to treatment by increasing the number of quality-assured generic medicines on the market. Sofosbuvir, 400 mg tablet, is manufactured by Mylan Laboratories Ltd., India.

    22 July 2017 | World Health Organization
  • Targeting MSM with HIV: Treatment as Prevention in the Netherlands

    As part of Dutch HIV guidelines, all individuals with HIV are screened for hepatitis C. Anne Boerekamps, MD, of Erasmus University Medical Center in Rotterdam, the Netherlands, spoke with HCV Next about the Dutch approach, the relevant data, and other topics associated with screening and treating MSM.

    18 July 2017 | Healio Hepatology
  • State HCV Incidence and Policies Related to Preventive Services, and Treatment Services for Persons Who Inject Drugs

    The authors of this analysis examined state laws governing access to safe infection equipment and Medicaid policies related to HCV treatment for people who inject drugs (PWID) in all 50 states and DC.

    12 May 2017 | CDC
  • US: New Hepatitis C Infections Nearly Tripled over Five Years

    Over just five years, the number of new hepatitis C virus infections reported to CDC has nearly tripled, reaching a 15-year high, according to new preliminary surveillance data released today by the Centers for Disease Control and Prevention (CDC).

    12 May 2017 | CDC
  • New report halves the number of people infected with hepatitis C worldwide

    A new World Health Organization (WHO) report chops the estimated number of people around the world living with the liver-damaging hepatitis C virus (HCV) in half—but the drop has nothing to do with the recent advent of powerful drugs that cure the disease for most everyone. The dramatic drop occurred primarily because of tests that measured HCV’s genetic material, RNA, in people. Previous epidemiological surveys tested whether people had antibodies against the virus, which is less precise.

    02 May 2017 | Science
  • New Canadian guideline: No screening for hepatitis C in adults not at increased risk

    The Canadian Task Force on Preventive Health Care recommends against screening for chronic hepatitis C virus in adults at low risk in a guideline published in Canadian Medical Association Journal.

    25 April 2017 | Eurekalert Inf Dis
  • New hepatitis data highlight need for urgent global response

    New WHO data reveal that an estimated 325 million people worldwide are living with chronic hepatitis B virus (HBV) or hepatitis C virus (HCV) infection. The WHO Global hepatitis report, 2017 indicates that the large majority of these people lack access to life-saving testing and treatment. As a result, millions of people are at risk of a slow progression to chronic liver disease, cancer, and death.

    21 April 2017 | World Health Organization
  • Optimism About HCV Treatment Comes With Caveats

    Despite significant advances in treatment for individuals with HCV infection, several important issues prevail in this patient population.

    22 March 2017 | Medscape
  • Hepatitis C in the UK

    The most recent national estimates suggest that around 214,000 individuals are chronically infected with hepatitis C virus (HCV) in the UK; 160,000 of these are in England.

    16 March 2017 | Public Health England
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.